Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: dalroi who wrote (1659)	9/16/2000 4:51:40 PM
From: sim1	Read Replies (1) \| Respond to of 52153

>>INCY (Janus hold a lot around 200)<< I think the Janus $211 figure was per presplit share.

To: dalroi who wrote (1659)	9/16/2000 4:57:56 PM
From: smh	Read Replies (1) \| Respond to of 52153

<seems taxloss season is going to start in the us for institutionals... so why not make a list of possible candidates> Oh Boy!... another buying op for INCY. Actually, I have been thinking about this. Last year DAK put together a "taxSELL" portfolio. I went back to see what I could learn, but the portfolio is gone and could only find a few related posts. As I recall, there was indeed a worthwhile bounce in early Nov. and DAK closed out the port. after 1/1. Of course, by that time everything was taking off. Perhaps we can get DAK to come back as a consultant. Regards SMH